• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低强度体外冲击波治疗勃起功能障碍: myths 与现实。

Low-intensity extracorporeal shock wave therapy for erectile dysfunction: Myths and realities.

机构信息

Department of Urology, University of Cagliari, Santissima Trinità Hospital, Cagliari, Italy.

Department of Urology, University of Florence, Careggi Hospital, Florence, Italy.

出版信息

Investig Clin Urol. 2023 Mar;64(2):118-125. doi: 10.4111/icu.20220327.

DOI:10.4111/icu.20220327
PMID:36882170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9995960/
Abstract

To review the evidence of clinical efficacy of low-intensity extracorporeal shock wave therapy (Li-ESWT) for the treatment of erectile dysfunction (ED). A search on PubMed using Medical Subject Headings terms [((low intensity extracorporeal shockwave therapy) OR (Li-ESWT)) AND (erectile dysfunction)] was conducted in August 2022, to obtain studies on the use of Li-ESWT for the treatment of ED. Its success rate in terms of International Index of Erectile Function-5 (IIEF-5) score and Erection Hardness Score (EHS) improvement was recorded and analysed. A total of 139 articles were reviewed. Overall, 52 studies were included in the final review. 17 studies were on vasculogenic ED, 5 on post pelvic surgery ED, 4 specifically on ED in diabetic patients, 24 on non-specified origin ED and 2 on mixed pathophysiological origin ED. The mean age of patients was 55.87±7.91 (standard deviation) years and the duration of ED was 4.36±2.08 years. The mean IIEF-5 score went from 12.04±2.67 at baseline to 16.12±5.72, 16.30±3.26 and 16.85±1.63 respectively at 3, 6 and 12 months. The mean EHS went from 2.00±0.46 at baseline to 2.58±0.60, 2.75±0.46 and 2.87±0.16 respectively at 3, 6 and 12 months. Li-ESWT may be a safe and efficacy option for the treatment and cure of ED. Further studies are needed to assess which patients are more suitable for this procedure and which Li-ESWT protocol can lead to the best outcomes.

摘要

回顾低强度体外冲击波治疗(Li-ESWT)治疗勃起功能障碍(ED)的临床疗效证据。2022 年 8 月,使用医学主题词([(低强度体外冲击波治疗)或(Li-ESWT)])在 PubMed 上进行了搜索,以获取关于 Li-ESWT 治疗 ED 的研究。记录并分析了其在国际勃起功能指数-5(IIEF-5)评分和勃起硬度评分(EHS)改善方面的成功率。共审查了 139 篇文章。总的来说,最终综述共纳入 52 项研究。17 项研究为血管性 ED,5 项为骨盆手术后 ED,4 项为糖尿病患者 ED,24 项为非特定病因 ED,2 项为混合病理生理病因 ED。患者的平均年龄为 55.87±7.91 岁(标准差),ED 持续时间为 4.36±2.08 年。平均 IIEF-5 评分从基线时的 12.04±2.67 分别提高到 3、6 和 12 个月时的 16.12±5.72、16.30±3.26 和 16.85±1.63。平均 EHS 从基线时的 2.00±0.46 分别提高到 3、6 和 12 个月时的 2.58±0.60、2.75±0.46 和 2.87±0.16。Li-ESWT 可能是治疗和治愈 ED 的一种安全有效的选择。需要进一步的研究来评估哪些患者更适合这种治疗方法,以及哪种 Li-ESWT 方案可以带来最佳效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/846c/9995960/2bc5788b65a8/icu-64-118-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/846c/9995960/4e1a8f32152d/icu-64-118-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/846c/9995960/ace551a8cc53/icu-64-118-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/846c/9995960/2bc5788b65a8/icu-64-118-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/846c/9995960/4e1a8f32152d/icu-64-118-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/846c/9995960/ace551a8cc53/icu-64-118-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/846c/9995960/2bc5788b65a8/icu-64-118-g003.jpg

相似文献

1
Low-intensity extracorporeal shock wave therapy for erectile dysfunction: Myths and realities.低强度体外冲击波治疗勃起功能障碍: myths 与现实。
Investig Clin Urol. 2023 Mar;64(2):118-125. doi: 10.4111/icu.20220327.
2
Low-intensity Extracorporeal Shock Wave Treatment Improves Erectile Function: A Systematic Review and Meta-analysis.低强度体外冲击波治疗改善勃起功能:系统评价和荟萃分析。
Eur Urol. 2017 Feb;71(2):223-233. doi: 10.1016/j.eururo.2016.05.050. Epub 2016 Jun 16.
3
Effect of Low-Intensity Extracorporeal Shock Wave on the Treatment of Erectile Dysfunction: A Systematic Review and Meta-Analysis.低强度体外冲击波治疗勃起功能障碍的疗效:系统评价和荟萃分析。
Am J Mens Health. 2019 Mar-Apr;13(2):1557988319846749. doi: 10.1177/1557988319846749.
4
Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction in Diabetic Patients.低强度体外冲击波治疗糖尿病患者勃起功能障碍。
Sex Med Rev. 2021 Oct;9(4):619-627. doi: 10.1016/j.sxmr.2019.06.007. Epub 2019 Aug 1.
5
The impact of extracorporeal shock wave therapy for the treatment of young patients with vasculogenic mild erectile dysfunction: A prospective randomized single-blind, sham controlled study.体外冲击波疗法治疗血管性轻度勃起功能障碍年轻患者的影响:一项前瞻性随机单盲、假对照研究。
Andrology. 2021 Sep;9(5):1571-1578. doi: 10.1111/andr.13007. Epub 2021 Aug 2.
6
[Efficacy and safety of low-intensity extracorporeal shock wave therapy in the treatment of ED: A meta-analysis of randomized controlled trials].低强度体外冲击波疗法治疗勃起功能障碍的疗效与安全性:随机对照试验的荟萃分析
Zhonghua Nan Ke Xue. 2019 Mar;25(3):257-264.
7
Effects of Low-intensity Extracorporeal Shockwave Therapy on Erectile Dysfunction: A Systematic Review and Meta-analysis.低强度体外冲击波疗法治疗勃起功能障碍的效果:系统评价和荟萃分析。
J Coll Physicians Surg Pak. 2022 Sep;32(9):1181-1186. doi: 10.29271/jcpsp.2022.09.1181.
8
Analysis of the Impact of Clinical Factors on Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction.分析临床因素对低强度体外冲击波治疗勃起功能障碍的影响。
Urol Int. 2022;106(10):1041-1049. doi: 10.1159/000520705. Epub 2022 Feb 10.
9
Systematic Review and Meta-Analysis of 16 Randomized Controlled Trials of Clinical Outcomes of Low-Intensity Extracorporeal Shock Wave Therapy in Treating Erectile Dysfunction.16 项低强度体外冲击波治疗勃起功能障碍的随机对照临床试验临床结局的系统评价和荟萃分析。
Am J Mens Health. 2022 Mar-Apr;16(2):15579883221087532. doi: 10.1177/15579883221087532.
10
The Basic Science Behind Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction: A Systematic Scoping Review of Pre-Clinical Studies.低强度体外冲击波治疗勃起功能障碍的基础科学:临床前研究的系统范围综述。
J Sex Med. 2019 Feb;16(2):168-194. doi: 10.1016/j.jsxm.2018.12.016.

引用本文的文献

1
Use of Secondary Reflectors for Enhanced ESWT Treatment of the Penis.使用二次反射器增强阴茎体外冲击波治疗
Biomedicines. 2025 Aug 13;13(8):1967. doi: 10.3390/biomedicines13081967.
2
A Narrative Review of Independent Treatment Methods for ED: Assessment of the Effectiveness of Diet, Supplements, Pharmacotherapy, and Physiotherapy.勃起功能障碍独立治疗方法的叙述性综述:饮食、补充剂、药物治疗和物理治疗的有效性评估
J Clin Med. 2025 Mar 31;14(7):2386. doi: 10.3390/jcm14072386.
3
Application of extracorporeal shockwave to regulate subchondral bone homeostasis through tumor necrosis factor-α/hypoxia-inducible factor-1α/vascular endothelial growth factor signaling pathway in treatment of talus bone marrow edema.

本文引用的文献

1
The Effect of Low-Intensity Shock Wave Therapy on Moderate Erectile Dysfunction: A Double-Blind, Randomized, Sham-Controlled Clinical Trial.低强度冲击波治疗对中度勃起功能障碍的影响:一项双盲、随机、假对照临床试验。
J Urol. 2022 Aug;208(2):388-395. doi: 10.1097/JU.0000000000002684. Epub 2022 May 6.
2
The Efficacy of Li-ESWT Combined With VED in Diabetic ED Patients Unresponsive to PDE5is: A Single-Center, Randomized Clinical Trial.李-ESWT 联合VED 治疗对 PDE5i 反应不佳的糖尿病 ED 患者的疗效:一项单中心、随机临床试验。
Front Endocrinol (Lausanne). 2022 Jun 23;13:937958. doi: 10.3389/fendo.2022.937958. eCollection 2022.
3
体外冲击波通过肿瘤坏死因子-α/低氧诱导因子-1α/血管内皮生长因子信号通路调节软骨下骨稳态在距骨骨髓水肿治疗中的应用。
Medicine (Baltimore). 2024 Nov 8;103(45):e40228. doi: 10.1097/MD.0000000000040228.
4
Efficacy and safety of low-intensity pulsed ultrasound (LIPUS) combined with tadalafil in the treatment of severe erectile dysfunction: a retrospective cohort study.低强度脉冲超声(LIPUS)联合他达拉非治疗重度勃起功能障碍的疗效和安全性:一项回顾性队列研究
Transl Androl Urol. 2024 Sep 30;13(9):2045-2054. doi: 10.21037/tau-24-154. Epub 2024 Sep 25.
5
Extracorporeal Shock Wave and Melatonin Alleviate Joint Capsule Fibrosis after Knee Trauma in Rats by Regulating Autophagy.体外冲击波联合褪黑素通过调节自噬减轻大鼠膝关节创伤后关节囊纤维化
Curr Mol Med. 2025;25(2):222-236. doi: 10.2174/0115665240339436240909100847.
6
Regenerative therapies as a potential treatment of erectile dysfunction.再生疗法作为治疗勃起功能障碍的一种潜在方法。
Investig Clin Urol. 2023 Jul;64(4):312-324. doi: 10.4111/icu.20230104.
Shockwave Therapy for Erectile Dysfunction: Which Gives the Best Results? A Retrospective National, Multi-Institutional Comparative Study of Different Shockwave Technologies.
冲击波疗法治疗勃起功能障碍:哪种方法效果最好?一项回顾性的全国性、多机构比较不同冲击波技术的研究。
Surg Technol Int. 2022 May 19;40:213-218. doi: 10.52198/22.STI.40.UR1556.
4
Are Radial Pressure Waves Effective for the Treatment of Moderate or Mild to Moderate Erectile Dysfunction? A Randomized Sham Therapy Controlled Clinical Trial.桡动脉压力波对治疗轻度至中度勃起功能障碍有效吗?一项随机假治疗对照临床试验。
J Sex Med. 2022 May;19(5):738-744. doi: 10.1016/j.jsxm.2022.02.010. Epub 2022 Mar 24.
5
EFFICACY AND SAFETY OF LOW-INTENSITY EXTRACORPOREAL SHOCKWAVE THERAPY FOR TREATMENT OF VASCULAR ERECTILE DYSFUNCTION IN NIGERIAN MEN: REPORT OF A STUDY IN IBADAN, SOUTH-WEST NIGERIA.低强度体外冲击波疗法治疗尼日利亚男性血管性勃起功能障碍的疗效与安全性:尼日利亚西南部伊巴丹的一项研究报告
Ann Ib Postgrad Med. 2021 Jun;19(1):8-14.
6
Analysis of the Impact of Clinical Factors on Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction.分析临床因素对低强度体外冲击波治疗勃起功能障碍的影响。
Urol Int. 2022;106(10):1041-1049. doi: 10.1159/000520705. Epub 2022 Feb 10.
7
Is Li-ESWT effective in diabetic patients with severe erectile dysfunction?李-ESWT 对严重勃起功能障碍的糖尿病患者有效吗?
Asian J Androl. 2022 Sep-Oct;24(5):521-524. doi: 10.4103/aja2021105.
8
Low intensity extracorporeal shockwave therapy for chronic pelvic pain syndrome patients with erectile dysfunction.低强度体外冲击波治疗勃起功能障碍的慢性盆腔疼痛综合征患者。
Medicine (Baltimore). 2022 Jan 14;101(2):e28546. doi: 10.1097/MD.0000000000028546.
9
A Prospective, Randomized, Double-Blinded, Clinical Trial Using a Second-Generation Duolith SD1 Low-Intensity Shockwave Machine in Males with Vascular Erectile Dysfunction.一项使用第二代Duolith SD1低强度冲击波治疗仪治疗男性血管性勃起功能障碍的前瞻性、随机、双盲临床试验。
World J Mens Health. 2023 Jan;41(1):94-100. doi: 10.5534/wjmh.210123. Epub 2022 Jan 2.
10
Adjuvant daily therapy with L-arginine 2,500 mg and tadalafil 5 mg increases efficacy and duration of benefits of low-intensity extracorporeal shock wave therapy for erectile dysfunction: A prospective, randomized, single-blinded study with 1-year follow-up.每日辅助使用 L-精氨酸 2500 毫克和他达拉非 5 毫克可提高低强度体外冲击波治疗勃起功能障碍的疗效和获益持续时间:一项具有 1 年随访的前瞻性、随机、单盲研究。
Investig Clin Urol. 2022 Jan;63(1):83-91. doi: 10.4111/icu.20210317.